An inter-ministerial committee has recommended that health supplements claiming to cure or mitigate diseases be classified as drugs. This shift aims to increase regulatory oversight by bringing these products under the purview of the CDSCO instead of the FSSAI, potentially impacting pricing and advertising practices.